The Filing Desk

FitLife Brands

FTLF · Nasdaq · Consumer Staples · Financials, fiscal 2016 to 2025

FTLF · Last close · November 19, 2026
$6.70
Value FitLife Brands yourself

FitLife Brands' revenue rose 26.4% to $82 million in fiscal 2025. Its operating margin was 12.3%, down from 20.4% a year earlier. Free cash flow was $7 million, down 22.9%. The diluted share count rose 0.8%.

FITLIFE BRANDS, INC. Latest fiscal year ended December 31, 2025 10-K filed March 31, 2026 · 0001437749-26-010680 Updated
Revenue
$82M
26.4%
Operating margin
12.3%
8.0 pts
Net income
$6M
29.6%
Free cash flow
$7M
22.9%
Return on equity
15.9%
12.6 pts
Market cap
$66M
Nov 19 close
P/E
9.7x
On $0.69 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

About these figures. Share counts and per-share figures for earlier years are restated for stock splits (2-for-1 and 4-for-1 and 1-for-10), so every year is on today's share basis. Return on capital for fiscal 2025 is blank: invested capital is small next to total assets (cash nearly matches equity and debt), so the ratio isn't meaningful. Net debt to EBITDA for fiscal 2025 is blank: the 10-K's structured data doesn't include every figure it needs. Piotroski F-score for fiscal 2025 is blank: the 10-K's structured data doesn't include every figure it needs.

Charts show fiscal years, from the 10-K filings.

What FitLife Brands does

FitLife Brands sells nutritional supplements and wellness products under a group of brands it has mostly bought over time. They include sports nutrition and weight loss products sold under NDS Nutrition, PMD Sports and iSatori; MusclePharm sports nutrition; Dr. Tobias supplements and skincare sold mainly on Amazon; and Irwin Naturals, a supplement maker it bought out of bankruptcy in August 2025 for $42.5 million, mostly paid with new bank loans.

It makes money by selling these products through several channels. Its NDS products go mainly to about 600 franchised GNC stores in the United States and to franchise stores abroad, and since the launch of its Metis Nutrition line it also sells through more than 1,300 company-owned GNC stores. Online sales matter most: about 49% of its 2025 sales came through Amazon's U.S. marketplace. Irwin sells mainly to mass retailers such as CVS, Walmart, Walgreens and Costco Canada, and to health food stores. It relies on a few outside suppliers and manufacturers to make its products.

The company is based in Omaha, Nebraska. It had 81 full-time employees at the end of 2025, up from 39 a year earlier, mainly because of the Irwin deal.

Its biggest risks, as it describes them

  • Relying on Amazon's U.S. marketplace for a large share of sales, where any limit on its selling would hurt.
  • Depending on GNC and a few other large partners for a big portion of its sales.
  • Debt taken on for acquisitions, and loan terms that limit what it can do.
  • Relying on a small number of outside suppliers and manufacturers.
  • Bad publicity about its products or ingredients, whose health benefits rest on limited clinical studies.
From FitLife Brands's annual report on Form 10-K, filed March 31, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2025, earnings per share grew 32.5% a year and net income 35.8% a year, as new shares raised the share count by 20% and diluted each share's earnings.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments1013142
Debt incl. finance leases002013—
Net debt (negative means net cash)−10−13199—
Net debt to EBITDA−1.6x−2.3x2.5x0.7x—
Debt to equity0.0x0.0x0.7x0.4x—
Interest coverage——7.4x9.6x5.4x
Current ratio4.4x5.4x1.4x1.6x1.5x
Quick ratio2.8x3.3x0.5x0.6x0.5x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project FitLife Brands' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What FitLife Brands says to expect

  • Fourth quarter 2026 onward: annual operating expenseThe initiative, which was substantially completed by the end of the third quarter, is anticipated to decrease the Company’s annual operating expense by approximately $1.2 million annually beginning in the fourth quarter of 2026.
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 17, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 20, 2025 and November 19, 2026, 4 insiders bought $71,989 of FitLife Brands shares on the open market, and none sold any.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Aug 19, 2026Shannon K. PappasDirectorBought1,000$10.25$10,250Form 4
Apr 10, 2026Grant Robert DawsonDirectorBought3,000$9.98$29,940Form 4
Apr 10, 2026Matthew LingenbrinkDirectorBought3,000$9.76$29,280Form 4
Jan 15, 2026Seth YakatanDirectorBought plan164$15.36$2,519Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score5 of 96 of 9—
Rule of 4090.8%37.2%35.4%
Altman Z''2.234.282.44
Accruals ratio2.7%−1.1%−1.4%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets rosePassFailFail
Cash from operations exceeds net incomeFailPassPass
Debt fell relative to assetsFailPass—
Current ratio roseFailPassFail
Share count didn't risePassFailFail
Gross margin roseFailPassFail
Revenue rose relative to assetsPassFailPass
F-score5 of 96 of 9—
Companies that report no gross profit are scored on the other eight.

Compare

Put FitLife Brands side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
FitLife BrandsFY2526.4%12.3%9.1%———
SolesenceFY2518.6%4.2%————Compare
MannatechFY25−8.3%−0.4%−4.0%—−4.1x2Compare
Niagen BioscienceFY2529.9%12.6%——−3.8x6Compare
Cronos GroupFY2524.6%−11.9%0.1%———Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue25181720222829536482
Revenue growth41.2%−29.7%−4.1%14.2%11.5%28.4%3.2%83.0%22.3%26.4%
Gross profit10578101212212832
Research and development——————————
Operating income0−91246681310
Net income0003954596
Diluted EPS (US$)0.05−1.160.050.290.970.560.450.540.910.63
Diluted shares (millions)889991010101010
Cash flow
Cash from operations01026444107
Capital expenditure000———0000
Free cash flow000———44107
Dividends paid0000000000
Share buybacks0002001000
Acquisitions0000000000
Stock-based compensation——00000———
Balance sheet at fiscal year end
Cash and short-term investments110061013142
Debt incl. finance leases10000002013—
Total assets157661722265558106
Total liabilities5643544282263
Shareholders' equity1123121721273644
Margins and ratios
Gross margin39.8%28.6%39.5%40.9%43.9%44.8%41.8%40.7%43.6%38.6%
Operating margin1.9%−50.3%3.8%12.8%20.0%22.3%19.8%14.3%20.4%12.3%
Net margin1.4%2.9%3.0%13.4%40.6%19.4%15.4%10.1%13.9%7.8%
Free cash flow margin0.1%2.7%1.5%———14.3%7.8%14.9%9.1%
Rule of 40 (growth + FCF margin)41.3%−27.0%−2.5%———17.5%90.8%37.2%35.4%
Return on capital8.9%—66.0%106.3%104.2%77.4%55.7%21.1%21.9%—
Return on equity6.7%55.8%33.5%100.3%118.1%37.0%22.9%21.9%28.4%15.9%
Return on assets2.2%4.6%7.7%42.3%77.9%28.4%18.8%13.1%15.8%7.7%
Net debt to EBITDA−0.7x—−0.4x−0.1x−1.4x−1.6x−2.3x2.5x0.7x—
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: FitLife Brands' Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with FitLife Brands.